Derma Sciences to Present at the Canaccord Genuity 33rd Annual Growth Conference

Before you go, we thought you'd like these...
Before you go close icon

Derma Sciences to Present at the Canaccord Genuity 33rdAnnual Growth Conference

PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (NAS: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, announced today that Edward J. Quilty, the Company's chairman and chief executive officer will present a corporate overview and update at the Canaccord Genuity 33rd Annual Growth Conference on Thursday, August 15th at 1:00 p.m. Eastern Time. The conference will be held at the InterContinental Boston, in Boston, Mass., from August 14th to August 15th.

To listen and view the presentation investors may visit the investor relations section of Derma Sciences' website at www.dermasciences.com. An archived copy of the presentation will also be available on Derma Sciences' website.


About Derma Sciences, Inc.

Derma Sciences is a medical technology company focused on three segments of the wound care marketplace: pharmaceutical wound care products; advanced wound care dressings to address chronic wounds including diabetic ulcers; and traditional dressings. The Company has begun its Phase 3 clinical trial in diabetic foot ulcer healing with DSC127, based on excellent Phase 2 data. Its MEDIHONEY® product is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown in clinical studies to be effective in a variety of indications. TCC-EZ® is its gold-standard total contact casting system for diabetic foot ulcers. Other novel products introduced into the $14 billion global wound care market include XTRASORB® for better management of wound exudate, and BIOGUARD® for infection prevention.

For more information please visit www.dermasciences.com.



Derma Sciences, Inc.
Barry Wolfenson, 609-514-4744
Group President, Advanced Wound Care and Pharmaceutical Development
bwolfenson@dermasciences.com
or
LHA, Inc.
Investors
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com
@LHA_IR_PR

KEYWORDS:   United States  North America  Massachusetts  New Jersey

INDUSTRY KEYWORDS:

The article Derma Sciences to Present at the Canaccord Genuity 33rd Annual Growth Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners